TheEdgeResearch
Home / Stocks / LH

Labcorp Holdings Inc. (LH)

NYSE Healthcare Medical - Diagnostics & Research
$326.89 ▼ -1.39%
Market Cap
$26.80B
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
0.84
52-Wk Range
244.52-341.8
CEO
Adam H. Schechter
Country
US
Currency
USD

Labcorp Holdings Inc. operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Burlington, NC, US. The stock last traded at $326.89, down 1.39% on the session, giving a market capitalisation of $26.80B. On trailing twelve-month figures it carries a trailing P/E of 26.86, a net margin of 7.0%. Its beta of 0.84 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
26.86
Price / Sales
1.87
Price / Book
3.10
EV / EBITDA
15.54
Gross margin
27.8%
Operating margin
11.3%
Net margin
7.0%
Return on equity
Debt / equity
0.79
Current ratio
1.80
Dividend yield
0.9%
Payout ratio
23.9%
Company profile
Exchange
New York Stock Exchange
Employees
71,000
IPO date
1990-03-29
Headquarters
Burlington, NC, US
About Labcorp Holdings Inc.

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Comparable companies

Labcorp Holdings Inc. is most often compared with the following Healthcare names:

BIIBDGXDXCMILMNINCYSTEUTHRWATWSTZBH
More research on LH
LH technical analysis LH TheEdge Score Compare against peers
Open full interactive analysis & DCF →